PharmCAT.NET

Биостатистика, фармакокинетика и клинические исследования.

  • Домашняя страница
    • О сайте
  • Материалы
    • Быстрые команды R Project
    • Ссылки
  • Инструменты
    • Рандомизационный список
  • Блог
    • Статистика
    • Phoenix WinNonlin
    • IT
    • Путевые заметки
  • Контакты
    • Контактные данные
    • Обратная связь
    • Консультации
    • Конфиденциальность
  • Профиль
    • Войти
    • Зарегистрироваться

Войти

Зарегистрироваться
Забыли пароль?

Свежие записи

  • Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
  • Главные ошибки при формировании базы данных в MS Excel
  • Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4
  • Julia:ReplicateBE – release 0.2.0
  • ClinicalTrialUtilities: обзор

Галерея

IMG-20170807-WA0039
DJI 0010
DJI 0029
20180814 212423
20180815 151800
20180131 170331
  • Chapter 6 - Veterinary Medicine
    Source: FDA - What's New: Drugs RSS Feed Published on 2022-06-29 By FDA
  • Medication Health Fraud
    Source: FDA - What's New: Drugs RSS Feed Published on 2022-06-29 By FDA
  • Patent Certifications and Suitability Petitions
    Source: FDA - What's New: Drugs RSS Feed Published on 2022-06-29 By FDA
  • Bryant Ranch Prepack Inc. Issues Voluntary Nationwide Recall of Morphine Sulfate 30 mg Extended Release and Morphine Sulfate 60 mg Extended-Release Due to Label-Mix Up
    Source: FDA - What's New: Drugs RSS Feed Published on 2022-06-29 By FDA
  • Using Methods from PFDD Guidance 1 and Guidance 2 as Tools for Including Patient Experience Data in Clinical Trials: Who to Ask and How to Ask - 06/30/2022
    Source: FDA - What's New: Drugs RSS Feed Published on 2022-06-29 By FDA
  • What's New Related to Drugs
    Source: FDA - What's New: Drugs RSS Feed Published on 2022-06-29 By FDA
  • Condition-Specific Meeting Reports and Other Information Related to Patients' Experience
    Source: FDA - What's New: Drugs RSS Feed Published on 2022-06-29 By FDA
  • Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
    Source: FDA - What's New: Drugs RSS Feed Published on 2022-06-29 By FDA
  • Biologics PREA Reviews and Labeling Changes
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2022-06-29 By FDA
  • Patient-Focused Drug Development: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments
    Source: FDA - What's New: Drugs RSS Feed Published on 2022-06-29 By FDA
  • Guidance Recap Podcast: Selecting, Developing or Modifying Fit-for-Purpose Clinical Outcomes Assessments
    Source: FDA - What's New: Drugs RSS Feed Published on 2022-06-29 By FDA
  • Vaccines Protect Children From Harmful Infectious Diseases
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2022-06-29 By FDA
  • Human medicines European public assessment report (EPAR): Saxenda, liraglutide, Obesity;Overweight, Date of authorisation: 23/03/2015, Revision: 12, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2022-06-29
  • Human medicines European public assessment report (EPAR): HBVaxPro, hepatitis B vaccine (recombinant DNA), Hepatitis B;Immunization, Date of authorisation: 27/04/2001, Revision: 30, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2022-06-29
  • Human medicines European public assessment report (EPAR): Rotarix, rotavirus vaccine, live, Immunization;Rotavirus Infections, Date of authorisation: 21/02/2006, Revision: 40, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2022-06-29
Предыдущие записи
Тема: Scaffold от Danny Cooper.